Intestinal obstruction and perforation following sucralfate administration in a very low birth weight infant

Area of Science:

• Neonatal Medicine
• Pediatric Gastroenterology
• Pharmacology

Background:

• Premature infants, especially those with very low birth weight, are at high risk for stress ulcers.
• Sucralfate is often used for stress ulcer prophylaxis in neonates due to its cytoprotective properties.
• The safety and efficacy of sucralfate in this vulnerable population require careful consideration.

Observation:

• A case report details an infant with very low birth weight who developed intestinal obstruction and perforation.
• The adverse events occurred following the administration of sucralfate.
• This clinical observation raises concerns about a potential causal link.

Findings:

• The case suggests a possible association between sucralfate use and severe gastrointestinal complications in extremely preterm infants.
• Intestinal obstruction and perforation represent serious, potentially life-threatening adverse effects.
• Further investigation is warranted to understand the mechanism and incidence of these complications.

Implications:

• Clinicians should exercise caution when prescribing sucralfate for stress ulcer prophylaxis in very low birth weight infants.
• The findings necessitate a re-evaluation of current prophylactic strategies for stress ulcers in premature neonates.
• This case underscores the importance of vigilant monitoring for adverse drug reactions in neonatal intensive care units.